Exalon: EVMPD - It`s actually even only 207 Days.

The new EU Pharmacovigilance legislation constitutes one of the biggest changes in European Drug law since 1995, according to the European Medicines Agency (EMA). Significant changes are introduced into Pharmacovigilance and Regulatory Affairs business practice to enhance patient safety and to increase efficiency and transparency with regard to Pharmacovigilance.  

As one of the consequences, Marketing Authorisation Holders (MAH) are obliged to provide detailed structured data for all human medicinal products authorised in EU/EEA to the Eudravigilance Medicinal Product Dictionary (EVMPD) by July 02, 2012 the latest. 

To find more information please click here:  Exalon: EVMPD - It`s actually even only 207 Days.